Announced Fri, 10 Jul · 15:47 IST
Board meeting on 31 July 2026 to consider Q1 FY27 financial results
Results View source PDF
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹1933.30
prior close
₹1925.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.3-0.3-0.4+0.5+1.0+0.9-0.0+1.3+0.6————
Up moveDown movePending
AI summary
Sun Pharma's Board will meet on 31 July 2026 to consider and approve unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended 30 June 2026). The trading window for insiders is closed from 1 July to 2 August 2026. Investors should watch for the Q1 earnings announcement after the meeting.
Likely market impact
Routine intimation. No material impact until Q1 results are announced on or after 31 July.